Printer Friendly 14,759,108 articles and books

Periodicals Literature Keyword Title Author Topic

Member login User name    Password    Remember me Join us Forgot password?

Submit articles free

Browse Leukemia topic

Drug therapy subtopic

Articles 1-49 out of 49 article(s) Title Author Type Date Words New drug 'can kill leukaemia'. Nov 3, 2009 227 SCIENTISTS FIND A CURE FOR CANCER; Irish researchers claim new drug kills leukaemia cells. Nov 3, 2009 345 Large pharma collaborations foster Ambit Biosciences' growth: biotech pursues other partnerships for its developing leukemia treatment. Tiersten, Sylvia Company overview Sep 21, 2009 696 Drug to fight leukaemia; IN BRIEF . Sep 3, 2009 41 Enzyme modification may revolutionise leukaemia treatment. Jul 29, 2009 247 Therapy-related hematological disorders following conventional chemotherapy for lymphoid malignancies in children. Spasova, Mariya Ivanova; Stoyanova, Angelina Asenova; Moumdjiev, Ivan Nikolov Report Jul 1, 2009 2886 Wonder drug in fight on MS; HEALTH: Leukaemia treatment may combat multiple sclerosis. Oct 23, 2008 352 Calistoga Pharmaceuticals Initiates First Oncology Clinical Trial Of Novel PI3K Delta Inhibitor, CAL-101. Jul 10, 2008 455 In Depth Report Analyzes Three Major and Intertwined Areas of Cancer R&D Antibody Drug Target Leukemias and Lymphomas. Dec 19, 2007 438 No new patients for Merck, Vertex trials. Brief article Dec 3, 2007 145 AROUND THE WORLD..: Leukaemia drugs recall. Sep 17, 2007 43 Antioxidant and anti-inflammatory effects of products from Croton celtidifolius Bailon on carrageenan-induced pleurisy in rats. Nardi, G.M.; Junior, J.M. Siqueira; Monache, F. Delle; Pizzolatti, M.G.; Ckless, K.; Ribeiro-do-Vall Drug overview Feb 1, 2007 4913 Hana Biosciences Receives Orphan Drug Designation for Marqibo(R) (Vincristine Sulfate Liposomes Injection) for the Treatment of Acute Lymphoblastic Leukemia. Jan 16, 2007 863 INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for INNO-406 for the Treatment of Chronic Myelogenous Leukemia. Jan 4, 2007 687 ChemGenex Announces Granting of Fast Track Status for Ceflatonin(R) by FDA. Nov 14, 2006 883 Identifying Emerging Leukemia Products & Key Areas of Pharmaceutical R&D. Oct 20, 2006 414 NCCN Updates Chronic Myelogenous Leukemia Guidelines. Oct 3, 2006 579 Bioenvision to Expand into Japan and Southeast Asia; Japanese Health Officials Endorse Bioenvision's Leukemia Drug. Sep 18, 2006 912 Bioenvision to Formally Launch Evoltra(R) Throughout Europe; Bioenvision To Showcase Leukemia Drug At International Pediatric Oncology Conference. Sep 14, 2006 857 Dacogen(TM) (Decitabine) for Injection Receives U.S. Orphan Drug Designation for Patients with AML. Aug 10, 2006 780 Dacogen(TM) (Decitabine) For Injection Receives European Orphan Drug Designation for Patients With AML. Aug 1, 2006 784 FDA Approves Enzon's Oncaspar(R) for First-Line Use in Acute Lymphoblastic Leukemia. Jul 25, 2006 862 MGI PHARMA UNVEILS DACOGEN (DECITABINE) FOR INJECTION. Jul 1, 2006 779 MGI PHARMA Announces Commercial Availability of Dacogen(TM) (Decitabine) for Injection. May 26, 2006 952 Hana Biosciences Receives Orphan Drug Designation for Talotrexin (PT-523), For the Treatment of Acute Lymphoblastic Leukemia. May 22, 2006 931 U.S. FDA Approves Dacogen(TM) (Decitabine) for Injection; Dacogen(TM) Approved for Patients with all FAB Classifications of MDS; Commercial Launch Planned For Late May. May 3, 2006 1651 SGX stock flies. Weeks, Katie Brief article Apr 3, 2006 193 MS drug linked to one death in clinical trial. Wachter, Kerri Apr 1, 2006 179 Callisto CEO to Detail Clinical Progress of Anti-Cancer Drug Development and other Programs at BIO 2006 Conference; CEO to Present Data on Callisto Drug Candidates to Target Leukemia, Multiple Myeloma and Carcinoid Cancer. Mar 30, 2006 933 Callisto to Spotlight Drug Candidate Pipeline and Clinical Progress at Frankfurt Stock Day Investor Conference; Leading European Conference to Reinforce Callisto's Recognition and Strategic Relationships Internationally. Mar 23, 2006 928 Callisto Pharmaceuticals Clinical Study of Anti-Leukemia Drug L-Annamycin Expanded to Third Clinical Site; Roswell Park Cancer Institute Commences Enrollment of Adult Leukemia Patients in Phase I/IIa Clinical Trial. Mar 21, 2006 1015 Head lice shampoo 'linked to leukaemia'; CHEMICAL TREATMENTS COULD DOUBLE THE RISK OF CHILD CANCER, SAYS STUDY. Jan 17, 2006 501 Vaccine for Chronic Myeloid Leukemia Active in Patients with Persistent Disease; Vaccine Demonstrated Improved Molecular Remission Rate of Patients with Persistent CML After Imatinib; US Multi-center Trial Opened. Jan 5, 2006 815 Web Alert: Callisto to Host Investor Conference Call Today to Discuss Developments in Anti-Cancer Drug Trials and IP Growth; Senior Management to Provide Progress Report on Recent Achievements During Call Scheduled to Start 12 p.m. Eastern. Dec 12, 2005 723 Callisto Corporate Video Presentation Focuses on Company's Anti-Cancer Drug Candidates as Second Clinical Trial Starts; Video Presentation Spotlights Company's Drug Candidates to Treat Relapsed Leukemia and Multiple Myeloma Cancers. Dec 9, 2005 930 Callisto Details Clinical Research Progress on Proprietary Anti-Cancer Drugs and Strategic Initiatives for 2006; Expected Start of Pediatric Trial of L-Annamycin to Treat Children with Leukemia Among Goals Noted in Investor Presentation. Dec 7, 2005 1036 Callisto's CEO Dr. Gary Jacob Discusses Launch of Human Clinical Trial of Cancer Drug to Treat Relapsed Leukemia in Interview; CEO Outlines Medical Promise and Market for New Drug Treatment for Acute Lymphocytic Leukemia on BiomedDiscoveries.com. Dec 6, 2005 1165 Callisto Pharmaceuticals Announces Poster Presentation on Atiprimod at Major Scientific Meeting in December; Research on Atiprimod's Effect on Leukemia Cells to Be Presented at American Society of Hematology Annual Meeting. Dec 1, 2005 832 Enzon Files sBLA for First-Line Use of ONCASPAR(R); FDA Accepts Application for Review. Dec 1, 2005 835 Firm tests therapy on leukemia. Nov 30, 2005 120 Argos Therapeutics and DC Bio Corp. Announce New Clinical Trial to Begin for Chronic Lymphocytic Leukemia Using Argos' Personalized Dendritic Cell Vaccine. Nov 8, 2005 728 Feds put S.D. firm's cancer drug on fast track. Weeks, Katie Oct 31, 2005 246 Callisto CEO Video Spotlights Company's Drug Candidates to Treat Devastating Multiple Myeloma and Leukemia Blood Cancers; Drugs under Development as New Therapies for Patients Who Fail to Respond to Existing Treatments. Oct 14, 2005 649 Callisto Announces Availability of Presentation Outlining Drug Development Pipeline and Market Opportunities; Development Programs Include New Drugs to Treat Leukemia and Multiple Myeloma Cancers, and to Fight Biowarfare Threats. Oct 13, 2005 771 Callisto Pharmaceuticals' CEO to Discuss Company's Anti-Cancer Drug Candidates on Tradersnation.com Broadcast Tomorrow; CEO Dr. Gary Jacob to Discuss Company's Development Pipeline of New Treatments for Cancer, Other Diseases. Oct 10, 2005 755 Callisto CEO Dr. Gary Jacob Discusses Research Progress on New Anti-Cancer Drug Candidates in Interview with WallSt.net; Company Chief to Provide Corporate Overview of KAL's Drug Development Programs. Oct 7, 2005 730 Leukemia fighter: drug could combat resistant cases. Seppa, N. Jul 17, 2004 429 Leukemia treatment ineffective in rare cases. Sep 22, 2003 277 New drugs zap cancer cells with radiation. Wu, Corinna Brief Article Feb 22, 1997 568

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles